3/29/2023  7:09:08 PM Chg. +0.02 Volume Bid9:58:00 PM Ask9:58:00 PM Market Capitalization Dividend Y. P/E Ratio
9.35EUR +0.21% 9,119
Turnover: 86,131.91
9.36Bid Size: 350 9.65Ask Size: 1,000 2.01 bill.EUR 3.53% 3.31

Business description

SYNLAB Group is the largest European clinical laboratory and medical diagnostic services provider by revenue and number of tests. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry. Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
 

Management board & Supervisory board

CEO
Mathieu Floreani
Management board
Sami Badarani
Supervisory board
Prof. Dr. David Ebsworth, Marc Welters, Anastasya Molodykh- McFarlane, Barbara Lambert, Christian Salling, Dr. Bartl Wimmer, Dr. med. Ute Hasholzner, Dr. Stefan Graf, Iris Schopper, Karin Bierstedt, Peter Catterall, Rene Schmidt-Ferroud
 

Company data

Name: SYNLAB AG
Address: Moosacher Straße 88,D-80809 München
Phone: +49-89-307-602-0
Fax: -
E-mail: info@synlab.com
Internet: https://www.synlab.de/
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 12/31
Free Float: -
IPO date: -

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: ir@synlab.com

Main Shareholders

Cinven (Luxco 1) S.A.
 
46.13%
Novo Nordisk Foundation
 
19.55%
Freefloat
 
14.99%
Ontario Teachers' Pension Plan Board
 
9.59%
State of Qatar
 
4.99%
Dr. Bartl Wimmer
 
4.75%